InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
3
已披露卖出
0
T+90 胜率
67%
T+90 平均收益
+45.7%
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Garipalli Vivek, Director. Officer active across 1 company, notably Clover Health Investments, CORP. /de. In total, 8 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €2.6m. History available since 17 June 2024. The latest transaction was filed on 7 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Garipalli Vivek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
1,655,949 股0Class A Common StockSEC:0001801170-26-000013:0
415,000 股@ US$2.240.065% mcap50.0% 占其流量Class A Common StockSEC:0001801170-25-000207:0
标准退出：2025年11月5日 (T+90)
1,670,965 股0Class A Common StockSEC:0001801170-25-000027:0
531,700 股@ US$1.8826.6% 占其流量Class A Common StockSEC:0001801170-24-000172:0
标准退出：2024年11月7日 (T+90)
877,567 股@ US$1.1427.1% 占其流量Class A Common StockSEC:0001801170-24-000132:0
标准退出：2024年9月15日 (T+90)
1,561,065 股Class A Common StockSEC:0001801170-24-000039:0
1,569,594 股Class A Common StockSEC:0000895345-23-000261:0
3,342,698 股Class B Common StockSEC:0001628280-22-000730:0
8 条申报中的 8 条
About Garipalli Vivek
Vivek Garipalli is a Director and Chief Executive Officer of Clover Health Investments, Corp. /DE. He leads the company with a focus on strategy and growth. His experience in the health sector is an asset for developing innovative solutions.
